About Us

BioNano Genomics aims to make full genome understanding more accessible to clinicians and researchers in life science, translational research, plus those developing molecular diagnostics and improving personalized medicine.

To publish important novel discoveries, you need quicker, easier and more cost-effective ways to investigate entire genomes. And with studies revealing frequent functional structural variation in the genome, you need to see more of its architecture than you can through sequencing alone.

A revolutionary nanochannel technology developed at Princeton University has given us the potential to deliver all this. Since taking a worldwide license, BioNano Genomics has developed that technology into a flexible platform capable of providing high-resolution, single-molecule analysis of extremely long DNA.

By working with whole molecules, the soon-to-launch nanoAnalyzer System avoids amplification and shearing, while bypassing the ambiguities and time investment of large-scale data reassembly. It can also identify biologically significant structural variation, such as:

• Translocations (balanced and unbalanced)
• Inversions
• Deletions
• Duplications
• Copy number variation (CNV)